MRC Surgical Trial for Gastric Cancer

interim pathology results

I C Talbot, Peter Fayers, J Craven, J W L Fielding, P M Wrigley, A Cuschieri

Research output: Contribution to journalAbstract

Abstract

This trial was established in 1984 to see if radical surgery for gastric cancer could lead to survival figures comparable to the excellent results of Japanese
workers. In the five and a half years since the start of recruitment 246 patients have been randomised out of 478 treated by 47 surgeons in 30 centres; 120 patients have been treated by conventional (RI) gastrectomy and 126 by a
radical operation (R2), with more extensive node excision and removal of spleen and body of pancreas (except when the carcinoma is limited to the antrum).
The histology of 206 cases has been examined and shows invasion to the serosa or subserosa in 63%, compared with the opinion of the surgeon at operation that there was definite or suspected serosal involvement in 64%. Surprisingly, 21% of tumours are TI (early gastric cancer). Sixty five per cent of tumours are Lauren intastinal type and 19% are diffuse. The data concerning node status and
patient survival are incomplete at present. These preliminary findings confirm a close similarity to histological tumour types in other series but show a high proportion of early gastric cancers.
Original languageEnglish
Pages (from-to)A1202
JournalGut
Volume31
Issue number10
Publication statusPublished - Oct 1990

Fingerprint

Stomach Neoplasms
Pathology
Serous Membrane
Neoplasms
Survival
Gastrectomy
Patient Selection
Pancreas
Histology
Spleen
Carcinoma
Surgeons

Cite this

Talbot, I. C., Fayers, P., Craven, J., Fielding, J. W. L., Wrigley, P. M., & Cuschieri, A. (1990). MRC Surgical Trial for Gastric Cancer: interim pathology results. Gut, 31(10), A1202.

MRC Surgical Trial for Gastric Cancer : interim pathology results. / Talbot, I C; Fayers, Peter; Craven, J; Fielding, J W L ; Wrigley, P M; Cuschieri, A.

In: Gut, Vol. 31, No. 10, 10.1990, p. A1202.

Research output: Contribution to journalAbstract

Talbot, IC, Fayers, P, Craven, J, Fielding, JWL, Wrigley, PM & Cuschieri, A 1990, 'MRC Surgical Trial for Gastric Cancer: interim pathology results', Gut, vol. 31, no. 10, pp. A1202.
Talbot IC, Fayers P, Craven J, Fielding JWL, Wrigley PM, Cuschieri A. MRC Surgical Trial for Gastric Cancer: interim pathology results. Gut. 1990 Oct;31(10):A1202.
Talbot, I C ; Fayers, Peter ; Craven, J ; Fielding, J W L ; Wrigley, P M ; Cuschieri, A. / MRC Surgical Trial for Gastric Cancer : interim pathology results. In: Gut. 1990 ; Vol. 31, No. 10. pp. A1202.
@article{3bd2ee6bbb554ae8bc734435eaff3022,
title = "MRC Surgical Trial for Gastric Cancer: interim pathology results",
abstract = "This trial was established in 1984 to see if radical surgery for gastric cancer could lead to survival figures comparable to the excellent results of Japaneseworkers. In the five and a half years since the start of recruitment 246 patients have been randomised out of 478 treated by 47 surgeons in 30 centres; 120 patients have been treated by conventional (RI) gastrectomy and 126 by aradical operation (R2), with more extensive node excision and removal of spleen and body of pancreas (except when the carcinoma is limited to the antrum).The histology of 206 cases has been examined and shows invasion to the serosa or subserosa in 63{\%}, compared with the opinion of the surgeon at operation that there was definite or suspected serosal involvement in 64{\%}. Surprisingly, 21{\%} of tumours are TI (early gastric cancer). Sixty five per cent of tumours are Lauren intastinal type and 19{\%} are diffuse. The data concerning node status andpatient survival are incomplete at present. These preliminary findings confirm a close similarity to histological tumour types in other series but show a high proportion of early gastric cancers.",
author = "Talbot, {I C} and Peter Fayers and J Craven and Fielding, {J W L} and Wrigley, {P M} and A Cuschieri",
year = "1990",
month = "10",
language = "English",
volume = "31",
pages = "A1202",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "10",

}

TY - JOUR

T1 - MRC Surgical Trial for Gastric Cancer

T2 - interim pathology results

AU - Talbot, I C

AU - Fayers, Peter

AU - Craven, J

AU - Fielding, J W L

AU - Wrigley, P M

AU - Cuschieri, A

PY - 1990/10

Y1 - 1990/10

N2 - This trial was established in 1984 to see if radical surgery for gastric cancer could lead to survival figures comparable to the excellent results of Japaneseworkers. In the five and a half years since the start of recruitment 246 patients have been randomised out of 478 treated by 47 surgeons in 30 centres; 120 patients have been treated by conventional (RI) gastrectomy and 126 by aradical operation (R2), with more extensive node excision and removal of spleen and body of pancreas (except when the carcinoma is limited to the antrum).The histology of 206 cases has been examined and shows invasion to the serosa or subserosa in 63%, compared with the opinion of the surgeon at operation that there was definite or suspected serosal involvement in 64%. Surprisingly, 21% of tumours are TI (early gastric cancer). Sixty five per cent of tumours are Lauren intastinal type and 19% are diffuse. The data concerning node status andpatient survival are incomplete at present. These preliminary findings confirm a close similarity to histological tumour types in other series but show a high proportion of early gastric cancers.

AB - This trial was established in 1984 to see if radical surgery for gastric cancer could lead to survival figures comparable to the excellent results of Japaneseworkers. In the five and a half years since the start of recruitment 246 patients have been randomised out of 478 treated by 47 surgeons in 30 centres; 120 patients have been treated by conventional (RI) gastrectomy and 126 by aradical operation (R2), with more extensive node excision and removal of spleen and body of pancreas (except when the carcinoma is limited to the antrum).The histology of 206 cases has been examined and shows invasion to the serosa or subserosa in 63%, compared with the opinion of the surgeon at operation that there was definite or suspected serosal involvement in 64%. Surprisingly, 21% of tumours are TI (early gastric cancer). Sixty five per cent of tumours are Lauren intastinal type and 19% are diffuse. The data concerning node status andpatient survival are incomplete at present. These preliminary findings confirm a close similarity to histological tumour types in other series but show a high proportion of early gastric cancers.

M3 - Abstract

VL - 31

SP - A1202

JO - Gut

JF - Gut

SN - 0017-5749

IS - 10

ER -